UCMSC-Exo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCMSC-Exo, covering 2025-03-21 to 2025-03-21. Get the full timeline:
Most recent: Clinical Trial Update: UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia [Phase 1]